Dir
Mudit K. Jain, PhD, MBA is a Founding General Partner at Treo Ventures, a medical device-focused venture capital firm, and has served as a Director on the board of CVRx, Inc. (NASDAQ: CVRX) since July 2020.[[1]](https://avivomed.com/muditjain/)[[2]](https://treovp.com/our-team/mudit-k-jain/)[[4]](https://www.barostim.com/healthcare-professionals/our-team/) He is also the CEO and co-founder of NuXcel, a bioelectronics-focused medical device accelerator, and co-founder and Chairman of companies including ShiraTronics, Inc., Avivomed, Inc., and iVEAcare, Inc., where he has helped raise over $175 million in funding.[[1]](https://avivomed.com/muditjain/)[[2]](https://treovp.com/our-team/mudit-k-jain/)
With over 25 years in the medical device industry as a venture capitalist, serial entrepreneur, and operator, Jain previously served as a General Partner at Synergy Life Science Partners and led Johnson & Johnson Development Corporation’s medical device investments in the Midwest and East Coast.[[1]](https://avivomed.com/muditjain/)[[2]](https://treovp.com/our-team/mudit-k-jain/)[[4]](https://www.barostim.com/healthcare-professionals/our-team/) Earlier, he held operational roles at Guidant Corporation’s Cardiac Rhythm Management Division, contributing to device technologies for heart failure and cardiac ablation, and worked at startups like Epicor, Inc. and Cardiac Pathways Corporation.[[1]](https://avivomed.com/muditjain/)[[2]](https://treovp.com/our-team/mudit-k-jain/) Jain holds a PhD in Biomedical Engineering from Duke University, an MBA from The Wharton School, and a B.E. in Electrical Engineering from VNIT, Nagpur, India, where he was a gold medalist; he also holds eight patents and has authored peer-reviewed publications.[[2]](https://treovp.com/our-team/mudit-k-jain/)
View full insider profile →
